Keywords: novo, expands, rights, aradigm, aerx, idms, danish

Novo expands rights to Aradigm's AERx iDMS

Article | 04 October 2004

Print This

Danish drugmaker Novo Nordisk says it has extended its existing agreement with the USA's Aradigm Corp to obtain full development ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in